
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5474296
[patent_doc_number] => 20090247462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'FGF VARIANTS AND METHODS FOR USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/416435
[patent_app_country] => US
[patent_app_date] => 2009-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26318
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12416435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/416435 | FGF variants and methods for use thereof | Mar 31, 2009 | Issued |
Array
(
[id] => 5404491
[patent_doc_number] => 20090239805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'HUMAN 3 RELAXIN'
[patent_app_type] => utility
[patent_app_number] => 12/412519
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15916
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412519
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412519 | HUMAN 3 RELAXIN | Mar 26, 2009 | Abandoned |
Array
(
[id] => 5569370
[patent_doc_number] => 20090252748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Sp35 Antibodies and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/410181
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 64753
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12410181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410181 | Sp35 antibodies and uses thereof | Mar 23, 2009 | Issued |
Array
(
[id] => 5474392
[patent_doc_number] => 20090247558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'USE OF THE CRH (CORTICOTROPIN RELEASING HORMONE) - UCN (UROCORTIN) SYSTEM IN THE TREATMENT OF INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/409300
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8836
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247558.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409300 | USE OF THE CRH (CORTICOTROPIN RELEASING HORMONE) - UCN (UROCORTIN) SYSTEM IN THE TREATMENT OF INFLAMMATORY DISEASES | Mar 22, 2009 | Abandoned |
Array
(
[id] => 5398287
[patent_doc_number] => 20090318350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'PAN-HER ANTAGONISTS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/398281
[patent_app_country] => US
[patent_app_date] => 2009-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318350.pdf
[firstpage_image] =>[orig_patent_app_number] => 12398281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/398281 | PAN-HER ANTAGONISTS AND METHODS OF USE | Mar 4, 2009 | Abandoned |
Array
(
[id] => 5480652
[patent_doc_number] => 20090203609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Use of IL-1 inhibitors for treating IL-1 mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/380535
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22298
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203609.pdf
[firstpage_image] =>[orig_patent_app_number] => 12380535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/380535 | Use of IL-1 inhibitors for treating IL-1 mediated diseases | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6142298
[patent_doc_number] => 20110129526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/918726
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17411
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918726
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918726 | COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE | Feb 18, 2009 | Abandoned |
Array
(
[id] => 5386258
[patent_doc_number] => 20090227503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'PARATHYROID HORMONE TREATMENT FOR ENHANCED ALLOGRAFT AND TISSUE-ENGINEERED RECONSTRUCTION OF BONE DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 12/368251
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16568
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227503.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368251
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368251 | PARATHYROID HORMONE TREATMENT FOR ENHANCED ALLOGRAFT AND TISSUE-ENGINEERED RECONSTRUCTION OF BONE DEFECTS | Feb 8, 2009 | Abandoned |
Array
(
[id] => 5409524
[patent_doc_number] => 20090123422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y'
[patent_app_type] => utility
[patent_app_number] => 12/319851
[patent_app_country] => US
[patent_app_date] => 2009-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5626
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123422.pdf
[firstpage_image] =>[orig_patent_app_number] => 12319851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319851 | Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y | Jan 12, 2009 | Abandoned |
Array
(
[id] => 6446163
[patent_doc_number] => 20100279935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'COMPOSITIONS FOR INDUCING LABOR AND ASSOCIATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/745819
[patent_app_country] => US
[patent_app_date] => 2008-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6495
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745819
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745819 | Oxytocin and melatonin compositions and associated methods for inducing labor | Dec 2, 2008 | Issued |
Array
(
[id] => 8625168
[patent_doc_number] => 08357663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Methods for enhancing fertility comprising administration of transfer factor'
[patent_app_type] => utility
[patent_app_number] => 12/325199
[patent_app_country] => US
[patent_app_date] => 2008-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9254
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12325199
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325199 | Methods for enhancing fertility comprising administration of transfer factor | Nov 29, 2008 | Issued |
Array
(
[id] => 7685464
[patent_doc_number] => 20100120677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'ACTIVITY OF RECOMBINANT EQUINE FOLLICLE STIMULATING HORMONE'
[patent_app_type] => utility
[patent_app_number] => 12/325084
[patent_app_country] => US
[patent_app_date] => 2008-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6919
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120677.pdf
[firstpage_image] =>[orig_patent_app_number] => 12325084
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325084 | Activity of recombinant equine follicle stimulating hormone | Nov 27, 2008 | Issued |
Array
(
[id] => 5564625
[patent_doc_number] => 20090137478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Hormone normalization therapy and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/291639
[patent_app_country] => US
[patent_app_date] => 2008-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22107
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291639 | Hormone normalization therapy comprising administration of aromatase inhibitor, follicle stimulating hormone, luteinizing hormone, human chorionic gonadotropin, gonadotropin hormone releasing hormone and/or progesterone | Nov 11, 2008 | Issued |
Array
(
[id] => 9008934
[patent_doc_number] => 08524228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Netrin-1 compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/740594
[patent_app_country] => US
[patent_app_date] => 2008-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 9548
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740594 | Netrin-1 compositions and methods of use thereof | Nov 2, 2008 | Issued |
Array
(
[id] => 7487340
[patent_doc_number] => 20110236350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/998463
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6814
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236350.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998463 | ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES | Oct 30, 2008 | Abandoned |
Array
(
[id] => 7487340
[patent_doc_number] => 20110236350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/998463
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6814
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236350.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998463 | ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES | Oct 30, 2008 | Abandoned |
Array
(
[id] => 5552743
[patent_doc_number] => 20090286729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'Epidermal Growth Factor Receptor Antagonists and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/261233
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7846
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12261233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/261233 | Epidermal Growth Factor Receptor Antagonists and Methods of Use | Oct 29, 2008 | Abandoned |
Array
(
[id] => 9345221
[patent_doc_number] => 08664369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'LH liquid formulations'
[patent_app_type] => utility
[patent_app_number] => 12/681688
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 2
[patent_no_of_words] => 14353
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681688
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681688 | LH liquid formulations | Oct 28, 2008 | Issued |
Array
(
[id] => 6501059
[patent_doc_number] => 20100215713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'SCAFFOLDS FOR FOLLICLE TRANSPLANTATION'
[patent_app_type] => utility
[patent_app_number] => 12/681075
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11082
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215713.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681075
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681075 | SCAFFOLDS FOR FOLLICLE TRANSPLANTATION | Sep 29, 2008 | Abandoned |
Array
(
[id] => 5265503
[patent_doc_number] => 20090118188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Activin-actriia antagonists and uses for decreasing or inhibiting FSH secretion'
[patent_app_type] => utility
[patent_app_number] => 12/284112
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 22934
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118188.pdf
[firstpage_image] =>[orig_patent_app_number] => 12284112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/284112 | Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion | Sep 16, 2008 | Issued |